Antitrypsin Deficiency (AATD) Augmentation Therapy Market Type, Regional Outlook, Future Scope, and Leading Players, Trends, Demand Growth Revenue Analysis Report to 2028
Posted on Jul 29 2022 5:10 AM
"Antitrypsin Deficiency Augmentation Therapy Market to Reach US$ 1959.8 Mn; Market Scope and overview, Growth Study, Demands"
The global alpha-1 antitrypsin deficiency augmentation therapy market has been boosted by recent FDA approval for Prolastin-C. According to a report published by Fortune Business Insights, titled “AATD Augmentation Therapy: Global Analysis, Insights and Forecast, 2019-2026”, the market will be valued at US$ 1959.8 Mn by the end of 2025. The estimated rise in market value from its 2017 value of US$ 1115.5 Mn implies that the market will exhibit a CAGR of 5.9% in the forecast period. Fortune Business Insights expects that factors such as regulatory approvals and improvements in augmentation therapies will drive the market in this period.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/aatd-augmentation-therapy-market-100169
Grifols SA’s AlfaCare Program Has Had a Positive Impact on the Global Market
In November 2018, Grifols Sa introduced AlfaCare, a therapy program aimed at providing training and counselling to patients diagnosed with AATD. Grifols stated that with AlfaCare, it aims to encourage new habits in AATD patients and help them manage their disease properly. Research studies have proven that a huge percentage of people diagnosed with AATD were unaware about the symptoms, effects, and ways to treat the disorder. AlfaCare was launched to overcome all such shortcomings and improve the quality of patient care, thereby ascertaining reduced fatality rate of AATD. Thus, AlfaCare has transformed AATD augmentation therapies worldwide and is likely to boost the global AATD augmentation therapy market in the forecast period.
To get to know more about the short-term and long-term impact of COVID-19 on this market,
North America to Dominate the Global Market
Rising number of AATD cases in North America is fuelling the demand for AATD augmentation therapy in this region. This in turn has led to the growth of AATD augmentation therapy market in North America and is likely to favor growth of the market in this region through the forecast period. There have been significant improvements in AATD diagnostic techniques used in many parts of Asia Pacific. Furthermore, the emphasis on AATD by the government in Asia Pacific is likely to enable growth in the regional market in the forthcoming years. Despite North America’s dominance, Asia Pacific will emerge as the fastest growing region in the forecast period.
Quick Buy - Antitrypsin Deficiency (AATD) Augmentation Therapy Market Research Report:
New Biological Approval for Prolastin C to Enable Growth of Global Market
In September 2017, Grifols received biologics license approval for Alpha-1 Proteinase Inhibitor to add a new liquid formulation to the currently licensed Prolastin C. The inclusion of this liquid may enable the launch of an additional alternative to the existing therapy. Clinical trials and proven efficacy have favored the approval for this product. With the latest addition to its product portfolio, Grifols will increase its stronghold in the global AATD augmentation therapy market. As Grifols’ products are used by a huge percentage of the global population, its new product approval will have a direct impact on the global market. Backed by successful therapies and efficient products, Grifols has accounted for the highest share in the global market. Recent product approvals have favoured the company and accounting to this, Grifols is likely to emrge dominant in the forecast period as well.
Table Of Contents :
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of AATD by major countries
- Pricing analysis of available products
- Recent industry developments such as partnerships, mergers & acquisitions
- Regulatory scenario for key countries
Ask for Customization of this Report:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Company Press Release
- Food Enzymes Market Share, Size, Trends, Competitive Analysis And Forecast Report By 2020-2027
- Controlled-release Fertilizers Market Size, Growth, Share, Latest Trends, Industry Overview And Forecast By 2026
- Southeast Asia Dietary Supplements Market Share, Size, Global Analysis, Key Growth, Drivers, Trends And Forecast By 2026
- Sake Market Revenue, Trends, Growth Factors, Global Demand, Industry Analysis And Forecast To 2026
- Sorbitol Market Size, Share, Covid-19 Impact, Global Demand, Revenue And Geographical Forecast Till 2026